CVE:IGX IntelGenx Technologies (IGX) Stock Forecast, Price & News C$0.58 +0.01 (+1.75%) (As of 10/6/2021) Add Compare Share Share Today's RangeC$0.58▼C$0.6050-Day RangeC$0.58▼C$0.5852-Week RangeC$0.17▼C$0.85Volume11,848 shsAverage Volume56,279 shsMarket CapitalizationC$87.32 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About IntelGenx Technologies (CVE:IGX) StockIntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.Read More Receive IGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IGX Stock News HeadlinesMay 11, 2023 | marketwatch.com8-K: IntelGenx Technologies Corp.April 27, 2023 | finance.yahoo.comIntelGenx Extends Period to Exercise Certain WarrantsMay 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.April 27, 2023 | finance.yahoo.comIntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal FilmApril 20, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Wednesday (IGX)April 17, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Monday (IGX)April 15, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Friday (IGX)April 13, 2023 | finance.yahoo.comIntelGenx Announces Organizational Changes to Support Global Growth StrategyMay 30, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. April 9, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp WT flat on Thursday (IGX-WT)March 29, 2023 | finance.yahoo.comIntelGenx Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 24, 2023 | finance.yahoo.comIntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023March 23, 2023 | finance.yahoo.comIntelGenx to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 – Conference Call to FollowMarch 9, 2023 | finance.yahoo.comIntelGenx to Participate in the 35th Annual Roth ConferenceMarch 9, 2023 | finance.yahoo.comCORRECTION – IntelGenx to Participate in the 35th Annual Roth ConferenceFebruary 16, 2023 | ca.finance.yahoo.comIntelGenx Technologies Corp. (IGX.TO)February 13, 2023 | finance.yahoo.comIIROC Trading Halt - IGX.WTJanuary 15, 2023 | msn.comIntelgenx Technologies, Cybin Among Top Psychedelic Movers Of TodayJanuary 9, 2023 | finance.yahoo.comIntelGenx Receives Fourth and Final Loan Tranche from ataiNovember 10, 2022 | finance.yahoo.comIntelGenx Reports Third Quarter 2022 Financial ResultsNovember 9, 2022 | finance.yahoo.comIntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™October 20, 2022 | finance.yahoo.comIntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® TechnologyOctober 18, 2022 | finance.yahoo.comIntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®September 20, 2022 | it.tmcnet.comNVIDIA Launches IGX Edge AI Computing Platform for Safe, Secure Autonomous SystemsSeptember 8, 2022 | finance.yahoo.comIntelGenx Announces Enrollment Reaches Halfway Mark in ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseAugust 11, 2022 | finance.yahoo.comIntelGenx Reports Second Quarter 2022 Financial ResultsAugust 4, 2022 | ca.finance.yahoo.comStocks in play: IntelGenx Technologies Corp.See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:IGX CUSIPN/A CIKN/A Webwww.intelgenx.com Phone514-331-7440FaxN/AEmployees48Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio164.62 Current Ratio2.77 Quick Ratio2.69 Sales & Book Value Annual SalesC$1.75 million Price / Sales49.95 Cash FlowC$0.08 per share Price / Cash Flow7.16 Book ValueC$0.05 per share Price / Book12.89Miscellaneous Outstanding Shares150,546,000Free FloatN/AMarket CapC$87.32 million OptionableNot Optionable BetaN/A Key ExecutivesDr. Horst G. Zerbe (Age 74)Chairman, CEO & Chairman of Scientific Advisory Board Comp: $240.75kMr. André Godin C.A. (Age 57)CPA, CPA, CA, Pres & CFO Comp: $223.6kMs. Nadine Paiement (Age 44)Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp Comp: $140.13kDr. Dana Matzen (Age 43)VP of Bus. & Corp. Devel. of IntelGenx Corp Comp: $171.43kStephen KilmerInvestor Relations OfficerDr. Rodolphe Obeid Ph.D. (Age 41)VP of Operations - IntelGenx Corp Mr. Tommy Kenny J.D. (Age 34)L.L.B., M.Sc., VP of Intellectual Property & Legal Affairs and Gen. Counsel of IntelGenx Corp Ms. Ingrid Zerbe (Age 67)Corp. Sec. More ExecutivesKey CompetitorsNovoheartCVE:NVH138267 (COM.TO)TSE:COMScythian BiosciencesCVE:SCYBPediapharmCVE:PDPProMIS NeurosciencesTSE:PMNView All CompetitorsInsidersHorst G. ZerbeBought 14,000 shares on 9/30/2022Total: C$2,380.00 ($0.17/share)André GodinBought 5,000 shares on 9/29/2022Total: C$850.00 ($0.17/share)André GodinBought 1,000 shares on 9/27/2022Total: C$180.00 ($0.18/share)Tommy KennyBought 23,500 shares on 9/22/2022Total: C$4,582.50 ($0.20/share)André GodinBought 20,000 shares on 9/21/2022Total: C$3,600.00 ($0.18/share)View All Insider Transactions IGX Stock - Frequently Asked Questions How have IGX shares performed in 2023? IntelGenx Technologies' stock was trading at C$0.58 at the beginning of the year. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58. View the best growth stocks for 2023 here. What other stocks do shareholders of IntelGenx Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Aurora Cannabis (ACB), New Age Brands (NF), Capstone Copper (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group (AC8), Cameco (CCJ) and Baylin Technologies (BYL). What is IntelGenx Technologies' stock symbol? IntelGenx Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX." How do I buy shares of IntelGenx Technologies? Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is IntelGenx Technologies' stock price today? One share of IGX stock can currently be purchased for approximately C$0.58. How much money does IntelGenx Technologies make? IntelGenx Technologies (CVE:IGX) has a market capitalization of C$87.32 million and generates C$1.75 million in revenue each year. How can I contact IntelGenx Technologies? The official website for the company is www.intelgenx.com. The company can be reached via phone at 514-331-7440. This page (CVE:IGX) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.